- GBP/USD snaps two-day losing streak, wavers between 1.3330 and 1.3341 off-late.
- UK’s Raab sounds optimistic over Brexit deal, EU’s Barnier is in London for negotiations.
- The UK to become the first western country to approve covid vaccine, Pfizer-BioNTech and AstraZeneca may gain initial approval.
- China’s tussle with the West intensifies, UK bans Huawei’s 5G kit installation from September 2021.
GBP/USD picks up bids around 1.333/40, up 0.31% on a day, while heading into London open on Monday. In doing so, the Cable cheers broad US dollar weakness, amid mixed catalysts at home, by keeping the week-start gap-up to 1.3313. Although the coronavirus (COVID-19) vaccine hopes can keep the bull hopeful, uncertainty surrounding Brexit can trim the monthly gains before the early December deadline.
MHRA is on the move, EU-UK stays at loggerheads…
Following the last week’s news that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) is up for reviewing AstraZeneca’s covid vaccine, the Financial Times (FT) conveyed, during the weekend, that the Pfizer-BioNTech product to battle the COVID-19 will be approved soon. This suggests the Tory government is pushing the moves to cure the pandemic.
Also on the positive side are chatters that regulatory authorities in Europe and the US are also up for approving the key vaccines, which in turn suggests an early recovery from the deadly virus.
On the contrary, the European Union (EU) Brexit negotiator Micher Bernier is in London for the final push over the trade deal. Although key hurdles like fisheries, governance and competition rules are still unsolved, chatters that the European Commission President Ursula von der Leyen and UK PM Boris Johnson will talk over the deal favor the GBP/USD buyers.
Read: UK’s Raab: Brexit talks in 'reasonable position'
Risk sentiment stays mixed with the US and the UK stock futures trading negative while the US 10-year Treasury yields stay directionless by press time.
While the Brexit and the vaccine updates are likely to keep the driver’s seat, the early-month US PMIs can offer intermediate entertainment to the markets. It should also be noted that developments surrounding the London-Beijing should also be closely observed as the joint efforts to battle China by the Western countries like the US, Australia and the UK weigh on the risk-tone and may weigh on the quote.
Technical analysis
With the confirmation of a short-term rising wedge bearish formation on the daily chart, GBP/USD bears are likely targeting October’s top near 1.3175 during further declines. However, sustained trading beyond 1.3400 will help the quote to refresh the yearly top beyond 1.3482.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD holds above 1.0700 ahead of key US data
EUR/USD trades in a tight range above 1.0700 in the early European session on Friday. The US Dollar struggles to gather strength ahead of key PCE Price Index data, the Fed's preferred gauge of inflation, and helps the pair hold its ground.
USD/JPY stays above 156.00 after BoJ Governor Ueda's comments
USD/JPY holds above 156.00 after surging above this level with the initial reaction to the Bank of Japan's decision to leave the policy settings unchanged. BoJ Governor said weak Yen was not impacting prices but added that they will watch FX developments closely.
Gold rises above $2,340 as US yields retreat
Gold gained traction and advanced above $2,340 in the European morning on Friday. The benchmark 10-year US Treasury bond yield stays in negative territory below 4.7% ahead of key inflation data from the US, helping XAU/USD stretch higher.
Sei Price Prediction: SEI is in the zone of interest after a 10% leap
Sei price has been in recovery mode for almost ten days now, following a fall of almost 65% beginning in mid-March. While the SEI bulls continue to show strength, the uptrend could prove premature as massive bearish sentiment hovers above the altcoin’s price.
US core PCE inflation set to signal firm price pressures as markets delay Federal Reserve rate cut bets
The core PCE Price Index, which excludes volatile food and energy prices, is seen as the more influential measure of inflation in terms of Fed positioning. The index is forecast to rise 0.3% on a monthly basis in March, matching February’s increase.